Author:
VARGHESE SAIRA SUSAN,MATHEWS SANTHOSH M.
Abstract
Objective: To design novel series of 1,3,4 thiadiazoles and to evaluate their anti-mycobacterial potency via In silico modeling.
Methods: In silico modeling comprising of Lipinski rule evaluation, ADMET prediction, Molecular docking and Simulation studies aimed to identify potent 1,3,4 thiadiazoles.
Results: The various physiochemical parameters and molecular descriptors of the proposed 1,3,4 thiadiazoles were predicted. And they exhibited good binding score compared with standard drug INH. The simulation studies showed minimal fluctuation of the ligand receptor complexes.
Conclusion: The MD simulation and binding affinity of designed 1,3,4 thiadiazoles proved their efficiency as InhA inhibitors. The potency of the selected derivatives can be confirmed by further in vitro and in vivo experiments.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference30 articles.
1. Talath S, Gadad AK. Synthesis, antibacterial, antitubercular activities of some 7[4-(5 amino 1,3,4 thiadiazole-2-sulfonyl)-piperazine-1-yl] fluroquinolonic derivatives. Eur J Med Chem. 2006;4:918-24.
2. Gundurao K, Vinayak H. Synthesis and evaluation of antitubercular activity of imidazo [2,1-b] 1,3,4 thiadizolederivatives. Bioorg Med Chem. 2016;14:69-80.
3. Ramprasad J, Nayak N, Dalimba U, Yogeeswari P, Sriram D. One-pot synthesis of new triazole–Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity. Bioorg Med Chem Lett. 2015;25(19):4169-73. doi: 10.1016/j.bmcl.2015.08.009, PMID 26298500.
4. Ramprasad J, Nayak N, Dalimba U. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents. Eur J Med Chem. 2015;106:75-84. doi: 10.1016/j.ejmech.2015.10.035, PMID 26520841.
5. Ketan CP, Nikitha HU. Review article on the synthesis of 1,3,4thiadiazole and its biological activity. J Chem Pharm Res. 2017;9:202-14.